Moreover, expression of type I and III IFN genes in our oropharyngeal samples were measured, and increased IFNL2 mRNA levels in mild COVID-19 patients as compared to uninfected controls were found (Supplementary Fig. 2e). This evidence concerns the gene IFNL2 and COVID-19.